A replay of the conference call will be available via telephone beginning approximately one hour after the call ends through Thursday, November 10, 2016. U.S. participants can access the replay by dialing 855-859-2056 and international participants can dial 404-537-3406. The access code for the replay is #2102394. A webcast of the conference call and slide presentation will be archived on the company's website for one year.

About Materialise

Materialise incorporates more than 25 years of 3D printing experience into a range of software solutions and 3D printing services, which Materialise seeks to form the backbone of the 3D printing industry. Materialise’s open and flexible solutions enable players in a wide variety of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, to build innovative 3D printing applications that aim to make the world a better and healthier place. Headquartered in Belgium, with branches worldwide, Materialise combines one of the largest groups of software developers in the industry with one of the largest 3D printing facilities in the world. For additional information, please visit: www.materialise.com.

Cautionary Statement on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, including statements concerning, among other things, current estimates of fiscal 2016 revenues, deferred revenue from annual licenses and maintenance and Adjusted EBITDA, results of operations, cash needs, capital expenditures, expenses, financial condition, liquidity, prospects, growth and strategies, and the trends and competition that may affect the markets, industry or us. Such statements are subject to known and unknown uncertainties and risks. When used in this press release, the words “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “will,” “may,” “could,” “might,” “aim,” “should,” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the expectations of management under current assumptions at the time of this press release. These expectations, beliefs and projections are expressed in good faith and the company believes there is a reasonable basis for them. However, the company cannot offer any assurance that our expectations, beliefs and projections will actually be achieved. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. We caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. All of the forward-looking statements are subject to risks and uncertainties that may cause the company's actual results to differ materially from our expectations, including risk factors described in the company's annual report on Form 20-F filed with the U.S. Securities and Exchange Commission on April 28, 2016. There are a number of risks and uncertainties that could cause the company's actual results to differ materially from the forward-looking statements contained in this press release.

The company is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise, unless it has obligations under the federal securities laws to update and disclose material developments related to previously disclosed information.

Consolidated income statements (Unaudited)
			For the three months ended 30 September									For the nine month period ended 30 September
(in thousands, except EPS)			2016			2016			2015			2016			2015
			U.S.$			euros			euros			euros			euros
Revenue			32,072			28,736			25,883			83,000			74,003
Cost of sales			(13,169)			(11,799)			(11,181)			(33,848)			(31,507)
Gross profit			18,903			16,937			14,702			49,152			42,496
						58.9%			56.8%			59.2%			57.4%
Research and development expenses			(4,899)			(4,389)			(4,566)			(13,521)			(13,444)
Sales and marketing expenses			(9,263)			(8,299)			(8,657)			(26,647)			(27,492)
General and administrative expenses			(5,900)			(5,286)			(3,956)			(15,225)			(11,278)
Other operating income			1,528			1,369			1,643			4,433			4,897
Other operating expenses			-			-			-			-
Operating profit			369			332			(834)			(1,808)			(4,821)
Financial expenses			(203)			(182)			(373)			(1,688)			(2,108)
Financial income			65			58			524			1,037			2,793
Share in loss of joint venture			(77)			(69)			(125)			(368)			(248)
Profit (loss) before taxes			154			139			(808)			(2,827)			(4,384)
Income taxes			(213)			(191)			(296)			(812)			(621)
Net profit (loss)			(59)			(52)			(1,104)			(3,639)			(5,005)
Net profit (loss) attributable to:
The owners of the parent			(59)			(52)			(1,104)			(3,639)			(4,952)
Non-controlling interest			-			-			-			-			(53)
Earnings per share attributable to
ordinary owners of the parent
Basic			(0.00)			(0.00)			(0.02)			(0.08)			(0.10)
Diluted			(0.00)			(0.00)			(0.02)			(0.08)			(0.10)
Weighted average basic			47,325			47,325			47,227			47,325			47,208
Weighted average with effect dilution			47,325			47,325			47,227			47,325			47,208

Consolidated statements of comprehensive income (Unaudited)
(in thousands, except EPS)
			For the three months ended 30 September									For the nine month period ended 30 September
			2016			2016			2015			2016			2015
			U.S.$			euros			euros			euros			euros
Net profit (loss) for the period			(59)			(52)			(1,104)			(3,639)			(5,005)
Other comprehensive income (loss)
Exchange differences on translation of foreign operations			(512)			(459)			(717)			(1,898)			759
Other comprehensive income (loss) , net of taxes			(512)			(459)			(717)			(1,898)			759
Total comprehensive income (loss) for the period, net of taxes			(571)			(511)			(1,821)			(5,537)			(4,246)
Total comprehensive income (loss) attributable to:
The owners of the parent			(571)			(511)			(1,821)			(5,537)			(4,193)
Non-controlling interest			-			-			-			-			(53)

	Consolidated statements of financial position (Unaudited)
				30 September			31 December
(in thousand euros)				2016			2015
Assets
	Non-current assets
	Goodwill			8,850			9,664
	Intangible assets			8,482			9,657
	Property, plant & equipment			42,124			38,400
	Investments in joint ventures			650			1,018
	Deferred tax assets			417			1,092
	Other financial assets			411			356
	Total non-current assets			60,934			60,187
	Current assets
	Inventory			6,215			5,387
	Trade receivables			23,143			22,843
	Held to maturity investments			-			-
	Other current assets			6,744			4,993
	Cash and cash equivalents			50,490			50,726
	Total current assets			86,592			83,949
Total assets				147,526			144,136
Equity and liabilities
	Equity
	Share capital			2,729			2,729
	Share premium			78,770			78,098
	Consolidated reserves			(2,224)			1,407
	Treasury shares			-			-
	Other comprehensive income			(1,177)			721
	Equity attributable to the owners of the parent			78,098			82,955
	Non-controlling interest			-			-
	Total equity			78,098			82,955
	Non-current liabilities
	Loans & borrowings			20,682			16,607
	Deferred tax liabilities			1,284			2,068
	Deferred income			-			92
	Other non-current liabilities			2,374			2,244
	Total non-current liabilities			24,340			21,011
	Current liabilities
	Loans & borrowings			5,734			4,482
	Trade payables			9,944			9,712
	Tax payables			489			255
	Deferred income			17,963			16,509
	Other current liabilities			10,958			9,212
	Total current liabilities			45,088			40,170
Total equity and liabilities				147,526			144,136

Segment P&L (Unaudited)
	In thousands euros			Materialise Software			Materialise Medical			Materialise Manufacturing			Total segments			Adjustments & eliminations			Consolidated
	For the three month period ended 30 September 2016
	Revenues			7,632			9,537			11,567			28,736			-			28,736
	Segment EBITDA			2,814			754			1,723			5,291			(2,816)			2,475
	Segment EBITDA %			36.9%			7.9%			14.9%			18.4%						8.6%
	For the three month period ended 30 September 2015
	Revenues			6,303			9,123			10,457			25,883			-			25,883
	Segment EBITDA			2,157			763			799			3,719			(2,724)			995
	Segment EBITDA %			34.2%			8.4%			7.6%			14.4%						3.8%
	For the nine month period ended 30 September 2016
	Revenues			22,044			27,849			33,080			82,973			27			83,000
	Segment EBITDA			7,181			238			2,410			9,829			(5,543)			4,286
	Segment EBITDA %			32.6%			0.9%			7.3%			11.8%						5.2%
	For the nine month period ended 30 September 2015
	Revenues			18,497			25,286			30,220			74,003			-			74,003
	Segment EBITDA			6,387			(325)			612			6,674			(6,618)			56
	Segment EBITDA %			34.5%			-1.3%			2.0%			9.0%						0.1%

Reconciliation of Net Profit/(Loss) to EBITDA and Adjusted EBITDA (Unaudited)
(in thousands)			For the three months ended 30 September
			2016			2015
			euros			euros
Net profit / (loss)			(52)			(1,104)
Income taxes			191			296
Financial expenses			181			373
Financial income			(58)			(524)
Share in loss of a joint venture			69			125
Depreciation & amortization			2,144			1,829
EBITDA			2,475			995
Non-cash stock-based compensation expenses (1)			358			180
Adjusted EBITDA			2,833			1,175

(1) Non-cash stock-based compensation expenses represent the cost of equity-settled and cash-settled share-based payments to employees.

Consolidated cash flow statements (Unaudited)
(in thousand euros)				For the nine month period ended 30 September
				2016		2015
				euros		euros
Operating activities
Net profit for the period				-3,639		-5,005
Non-cash and operational adjustments
	Depreciation of property, plant & equipment			4,669		3,816
	Amortization of intangible assets			1,425		1,061
	Share-based payment expense			718		652
	Loss (gain) on disposal of property, plant & equipment			-147		1
	Fair value adjustment contingent liabilities			54		-
	Movement in provisions and allowance for bad debt			-2		162
	Financial income			-126		-2,523
	Financial expense			668		1,733
	Impact of foreign currencies			55		55
	Share of loss of an associate or joint venture (equity method)			368		248
	Deferred tax expense (income)			225		46
	Income taxes			587		575
	Other			7		-
Working capital adjustments
	Increase in trade receivables and other receivables			-2,394		-1,644
	Decrease (Increase) in inventories			-828		-973
	Increase in trade payables and other payables			3,203		3,955
				4,843		2,159
	Income tax paid			-528		-530
Net cash flow from operating activities				4,315		1,629
Investing activities
	Purchase of property, plant & equipment			-6,816		-5,918
	Purchase of intangible assets			-871		-1,019
	Proceeds from the sale of property, plant & equipment, net			192		13
	Acquisition of subsidiary			-		-1,602
	Investments in joint-ventures			-		-500
	Proceeds from held to maturity investments			-		10,000
	Interest received			7		8
Net cash flow used in investing activities				-7,488		982
Financing activities
	Proceeds from loans & borrowings and convertible debt			7,004		324
	Repayment of loans & borrowings			-2,116		-3,889
	Repayment of finance leases			-1,293		-1,108
	Purchase of non-controlling interest			-		-1,377
	Capital increase in parent company			-		580
	Interest paid			-406		-399
	Other financial income / (expense)			-7		-34
Net cash flow from financing activities				3,182		-5,903
Net increase of cash and cash equivalents				9		-3,292
	Cash and cash equivalents at beginning of period			50,726		51,019
	Exchange rate differences on cash & cash equivalents			-245		1,007
	Cash & cash equivalents at end of period			50,490		48,734

« Previous Page 1 | 2 | 3 | 4  Next Page »